DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

LinksSchließen

Referenz

Kim HS, Kang J, Hwang D. et al.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.

Lancet 2020;
10257: 1079-1089

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: